Seeyond grew its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 46.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,347 shares of the semiconductor company’s stock after acquiring an additional 2,027 shares during the quarter. Seeyond’s holdings in Synopsys were worth $817,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of SNPS. Steward Partners Investment Advisory LLC lifted its holdings in shares of Synopsys by 2.2% during the second quarter. Steward Partners Investment Advisory LLC now owns 3,668 shares of the semiconductor company’s stock worth $472,000 after purchasing an additional 78 shares during the period. Greenleaf Trust lifted its holdings in shares of Synopsys by 1.9% during the second quarter. Greenleaf Trust now owns 4,355 shares of the semiconductor company’s stock worth $560,000 after purchasing an additional 80 shares during the period. Sigma Investment Counselors Inc. lifted its holdings in shares of Synopsys by 0.3% during the second quarter. Sigma Investment Counselors Inc. now owns 43,199 shares of the semiconductor company’s stock worth $5,559,000 after purchasing an additional 127 shares during the period. BB&T Securities LLC lifted its holdings in shares of Synopsys by 1.9% during the second quarter. BB&T Securities LLC now owns 7,459 shares of the semiconductor company’s stock worth $959,000 after purchasing an additional 139 shares during the period. Finally, Advisor Partners LLC lifted its holdings in shares of Synopsys by 4.3% during the second quarter. Advisor Partners LLC now owns 3,423 shares of the semiconductor company’s stock worth $441,000 after purchasing an additional 141 shares during the period. 89.84% of the stock is owned by institutional investors and hedge funds.

NASDAQ:SNPS traded down $1.90 during trading hours on Friday, reaching $135.49. The company had a trading volume of 33,902 shares, compared to its average volume of 1,129,784. Synopsys, Inc. has a 1-year low of $79.14 and a 1-year high of $146.66. The firm has a market cap of $20.65 billion, a PE ratio of 48.03, a price-to-earnings-growth ratio of 3.58 and a beta of 1.23. The business’s 50 day moving average price is $134.96 and its 200-day moving average price is $123.37. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.99 and a quick ratio of 0.90.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, August 21st. The semiconductor company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.03. The business had revenue of $853.00 million during the quarter, compared to analysts’ expectations of $831.03 million. Synopsys had a return on equity of 16.56% and a net margin of 18.94%. The business’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.95 earnings per share. On average, analysts expect that Synopsys, Inc. will post 3.15 earnings per share for the current fiscal year.

In related news, VP Sudhindra Kankanwadi sold 8,011 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $144.30, for a total transaction of $1,155,987.30. Following the completion of the sale, the vice president now directly owns 8,663 shares in the company, valued at $1,250,070.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Roy Vallee sold 15,596 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $128.95, for a total value of $2,011,104.20. Following the sale, the director now owns 52,641 shares of the company’s stock, valued at $6,788,056.95. The disclosure for this sale can be found here. Insiders sold 51,881 shares of company stock valued at $6,932,729 over the last 90 days. Company insiders own 1.84% of the company’s stock.

A number of equities research analysts recently commented on SNPS shares. Needham & Company LLC lifted their target price on Synopsys from $125.00 to $145.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. DA Davidson boosted their price target on Synopsys to $155.00 and gave the company a “positive” rating in a report on Thursday, August 22nd. Credit Suisse Group reissued a “positive” rating and issued a $150.00 price target (up from $125.00) on shares of Synopsys in a report on Thursday, August 22nd. Bank of America reissued an “average” rating on shares of Synopsys in a report on Wednesday, June 5th. Finally, Zacks Investment Research raised Synopsys from a “sell” rating to a “hold” rating and set a $142.00 price target for the company in a report on Monday, August 26th. Four equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $143.10.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Article: Dividend Aristocrat Index

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.